Investing.com - CEL-SCI (NYSE: CVM) reported third quarter EPS of $-0.57, $0.42 worse than the analyst estimate of $-0.15. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
CEL-SCI's stock price closed at $1.42. It is down -45.38% in the last 3 months and down -66.43% in the last 12 months.
CEL-SCI saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See CEL-SCI's stock price’s past reactions to earnings here.
According to InvestingPro, CEL-SCI's Financial Health score is "weak performance".
Check out CEL-SCI's recent earnings performance, and CEL-SCI's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar